US obesity rate drops as weight loss drugs gain popularity
TL;DR Summary
A recent survey indicates that the U.S. adult obesity rate has decreased to 37% in 2025, partly due to increased use of weight loss drugs like GLP-1 injectables (e.g., Ozempic, Wegovy), which have seen usage rise from 5.8% to 12.4% since 2024. The decline is most notable among adults aged 40-64, and despite the decrease, the U.S. still has a higher obesity rate compared to many Western countries.
- Obesity rate is declining as more Americans use weight loss drugs, survey finds CBS News
- Obesity Rate Declining in U.S. Gallup News
- Weight loss drugs are bringing down the country's obesity rate, a survey shows NPR
- The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating Ame Times of India
- The obesity rate in the US has declined. Are GLP-1s responsible? USA Today
Reading Insights
Total Reads
1
Unique Readers
15
Time Saved
2 min
vs 3 min read
Condensed
86%
483 → 68 words
Want the full story? Read the original article
Read on CBS News